Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil plus bupivacaine versus bupivacaine alone for prevention of post-spinal headache after cesarean section
IRCT201610162946N8Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sufentanil and bupivacaine in post-dural puncture headache (PDPH) (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
sufentanilbupivacaine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT201610162946N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201610162946N8.